Allred Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.87M | Buy |
7,426
+51
| +0.7% | +$11K | 0.61% | 42 |
|
|
2026
Q1 | $1.6M | Buy |
7,375
+69
| +0.9% | +$15.3K | 0.58% | 44 |
|
|
2025
Q4 | $1.67M | Sell |
7,306
-43
| -0.6% | -$9.79K | 0.6% | 44 |
|
|
2025
Q3 | $1.7M | Buy |
7,349
+58
| +0.8% | +$11.8K | 0.59% | 43 |
|
|
2025
Q2 | $1.35M | Sell |
7,291
-551
| -7% | -$102K | 0.51% | 47 |
|
|
2025
Q1 | $1.64M | Buy |
7,842
+28
| +0.4% | +$5.44K | 0.66% | 41 |
|
|
2024
Q4 | $1.39M | Sell |
7,814
-40
| -0.5% | -$7.35K | 0.54% | 45 |
|
|
2024
Q3 | $1.55M | Sell |
7,854
-61
| -0.8% | -$11.4K | 0.61% | 39 |
|
|
2024
Q2 | $1.36M | Buy |
7,915
+223
| +3% | +$36.9K | 0.52% | 40 |
|
|
2024
Q1 | $1.4M | Sell |
7,692
-177
| -2% | -$30.5K | 0.55% | 39 |
|
|
2023
Q4 | $1.22M | Buy |
7,869
+311
| +4% | +$45.3K | 0.53% | 40 |
|
|
2023
Q3 | $1.13M | Sell |
7,558
-234
| -3% | -$34.4K | 0.56% | 37 |
|
|
2023
Q2 | $1.05M | Sell |
7,792
-480
| -6% | -$70.4K | 0.52% | 40 |
|
|
2023
Q1 | $1.32M | Buy |
8,272
+181
| +2% | +$27.7K | 0.7% | 32 |
|
|
2022
Q4 | $1.31M | Buy |
8,091
+82
| +1% | +$12.6K | 0.72% | 30 |
|
|
2022
Q3 | $1.07M | Buy |
8,009
+634
| +9% | +$91K | 0.67% | 35 |
|
|
2022
Q2 | $1.13M | Sell |
7,375
-419
| -5% | -$64K | 0.71% | 35 |
|
|
2022
Q1 | $1.26M | Sell |
7,794
-489
| -6% | -$71K | 0.67% | 36 |
|
|
2021
Q4 | $1.12M | Sell |
8,283
-615
| -7% | -$72.6K | 0.54% | 45 |
|
|
2021
Q3 | $960K | Sell |
8,898
-628
| -7% | -$71.8K | 0.5% | 52 |
|
|
2021
Q2 | $1.07M | Sell |
9,526
-421
| -4% | -$47.4K | 0.53% | 48 |
|
|
2021
Q1 | $1.08M | Sell |
9,947
-121
| -1% | -$12.9K | 0.49% | 49 |
|
|
2020
Q4 | $1.08M | Buy |
10,068
+480
| +5% | +$46.1K | 0.59% | 46 |
|
|
2020
Q3 | $839K | Buy |
9,588
+45
| +0.5% | +$4.24K | 0.51% | 58 |
|
|
2020
Q2 | $936K | Buy |
9,543
+105
| +1% | +$9.24K | 0.59% | 48 |
|
|
2020
Q1 | $719K | Buy |
9,438
+249
| +3% | +$21.2K | 0.56% | 52 |
|
|
2019
Q4 | $814K | Sell |
9,189
-1,759
| -16% | -$146K | 0.44% | 56 |
|
|
2019
Q3 | $801K | Sell |
10,948
-121
| -1% | -$8.3K | 0.49% | 60 |
|
|
2019
Q2 | $821K | Sell |
11,069
-483
| -4% | -$38K | 0.47% | 60 |
|
|
2019
Q1 | $958K | Buy |
11,552
+99
| +0.9% | +$8.1K | 0.55% | 54 |
|
|
2018
Q4 | $1.05M | Buy |
+11,453
| New | +$1.01M | 0.71% | 39 |
|
Other funds holding ABBV
Allred Capital Management's ABBV Position: Q2 2026 in Review
Allred Capital Management increased its AbbVie (ABBV) stake by 0.69% in Q2 2026, buying an estimated $11K and bringing the position to 7,426 shares worth $1.87M. The position accounts for 0.61% of the portfolio, ranked #42.
Allred Capital Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Allred Capital Management held 7,426 shares of AbbVie worth $1.87M as of Q2 2026.
- Allred Capital Management bought 51 AbbVie shares in Q2 2026, an estimated $11K.
- AbbVie made up 0.61% of Allred Capital Management's portfolio in Q2 2026, its #42 holding.
- Allred Capital Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Allred Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.